{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:10:48Z","timestamp":1787015448925,"version":"build-2736575974"},"reference-count":41,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Generalized pustular psoriasis (GPP) is a rare, inflammatory skin disease characterized by widespread eruption of sterile pustules with or without systemic symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to describe the demographics of patients with GPP in Central and Eastern Europe (CEE), present the clinical characteristics of individual GPP flares and explore the current treatment landscape.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patient demographics were collected at the times of last observation and previous treatment. Characteristics of a patient's last (most recent) and most severe (from all documented episodes) flare were provided at clinician's discretion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty\u2010eight patients were recruited from 12 centres in nine CEE countries; median (range) age was 61 (16\u201392)\u2009years and 60.3% (35 out of 58) were female. The most common comorbidities were hypertension (43.1% [25 out of 58]) and hyperlipidaemia (32.8% [19 out of 58]). Thirty\u2010four patients (58.6%) presented with concomitant plaque psoriasis before or during the course of GPP. Data from two separate flares were recorded in 26 individuals; in 32 patients, the most recent flare was reported as the most severe. Over 90% of patients with a flare episode classified as most severe by clinicians were hospitalized, with &gt;75% of these individuals having a Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) total score of 3 or 4. Systemic symptoms were more common in patients with a GPPGA score of 3 or 4 but were also manifest in individuals with a GPPGA score \u22642. A significant correlation was observed between a combined systemic disease score of clinical and laboratory features and both GPPGA total score (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.385,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and GPPGA pustulation subscore (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.305,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Considerable heterogeneity in the presentation of GPP flares was observed, both between patients and within\u2010patient. All GPP flares were associated with a significant clinical burden, highlighting the unmet need for accurate and early diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.19808","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T06:20:03Z","timestamp":1706336403000},"page":"1531-1542","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characteristics and management of generalized pustular psoriasis (\n                    <scp>GPP<\/scp>\n                    ): Experience from the Central and Eastern Europe (\n                    <scp>CEE<\/scp>\n                    )\n                    <scp>GPP<\/scp>\n                    Expert Network"],"prefix":"10.1111","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7777-9444","authenticated-orcid":false,"given":"P.","family":"Wolf","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology Medical University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1296-6174","authenticated-orcid":false,"given":"R.","family":"Ceovic","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology School of Medicine University of Zagreb, University Hospital Centre Zagreb  Zagreb Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-3440","authenticated-orcid":false,"given":"C.","family":"Conrad","sequence":"additional","affiliation":[{"name":"Department of Dermatology Lausanne University Hospital  Lausanne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8044-2727","authenticated-orcid":false,"given":"K.","family":"Falkensteiner","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology Medical University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-7776","authenticated-orcid":false,"given":"T.","family":"Graier","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology Medical University of Graz  Graz Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ko\u0142t\u2010Kami\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Institute of Medical Sciences Medical College of Rzesz\u00f3w University  Rzesz\u00f3w Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1954-1416","authenticated-orcid":false,"given":"M.","family":"Marovt","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Medical Centre Maribor  Maribor Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4694-4977","authenticated-orcid":false,"given":"V.","family":"Mateeva","sequence":"additional","affiliation":[{"name":"Department of Dermatology Medical University of Sofia  Sofia Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-1545","authenticated-orcid":false,"given":"J.\u2010T.","family":"Maul","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital of Z\u00fcrich  Z\u00fcrich Switzerland"},{"name":"Faculty of Medicine University of Z\u00fcrich  Z\u00fcrich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7059-632X","authenticated-orcid":false,"given":"A. A.","family":"Navarini","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital of Basel  Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-464X","authenticated-orcid":false,"given":"A. C.","family":"Nicolescu","sequence":"additional","affiliation":[{"name":"Emergency Clinical Hospital Agrippa Ionescu  Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-6697","authenticated-orcid":false,"given":"G.","family":"Ratzinger","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology Medical University of Innsbruck  Innsbruck Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-9587","authenticated-orcid":false,"given":"L.","family":"Pavlovsky","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanzharovskaya","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2109-9014","authenticated-orcid":false,"given":"A.","family":"Szegedi","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Debrecen  Debrecen Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5573-1754","authenticated-orcid":false,"given":"A.","family":"Reich","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Institute of Medical Sciences Medical College of Rzesz\u00f3w University  Rzesz\u00f3w Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"131","article-title":"Pustular psoriasis: pathophysiology and current treatment perspectives","volume":"6","author":"Benjegerdes KE","year":"2016","journal-title":"Psoriasis (Auckl)"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14386"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-002-0371-6"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00655-y"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.01.032"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1708193"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18720"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013068"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14523"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16084"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/24755303221079814"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1648209"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14702"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14664"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12773"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13622"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00829-2"},{"key":"e_1_2_10_19_1","unstructured":"Thailand Food and Drug Administration.LUMICEF summary of product characteristics. 2019 [cited 2019 Mar 7]. Available from:https:\/\/www.fda.moph.go.th\/sites\/oss\/Drug%20Registration\/Lumicef%20Subcutaneous%20Injection%20210%20mg%20Syringe_1C%2015051\u201061%20(NBC)\/LUMICEF%20SUBCUTANEOUS%20_SPC(8\u201011\u201019).pdf"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13306"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15355"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00741-x"},{"issue":"3","key":"e_1_2_10_23_1","first-page":"E2","article-title":"Treatment of generalized pustular psoriasis of pregnancy with infliximab","volume":"107","author":"Beksac B","year":"2021","journal-title":"Cutis"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2014.26.6.787"},{"key":"e_1_2_10_25_1","first-page":"317","article-title":"Infliximab in combination with low\u2010dose acitretin in generalized pustular psoriasis: a report of two cases and review of the literature","volume":"15","author":"Kolt\u2010Kaminska M","year":"2021","journal-title":"Biologics"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2111563"},{"key":"e_1_2_10_27_1","unstructured":"GudjonssonJ ReichA BarkerJ PinkA ReynoldsNJ GriffithsCEM et\u00a0al.Imsidolimab an anti\u2010IL\u201036 receptor monoclonal antibody in the treatment of generalized pustular psoriasis: results from a phase 2 trial.European Academy of Dermatology and Venerology(Virtual Congress) 2021."},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22169048"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19178"},{"key":"e_1_2_10_30_1","unstructured":"FDA U.Spesolimab prescribing information. 2022 [cited 2022 Oct 28]. Available from:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761244s000lbl.pdf"},{"key":"e_1_2_10_31_1","unstructured":"Boehringer\u2010Ingelheim.European Commission approves SPEVIGO\u00ae (spesolimab) for generalized pustular psoriasis flares. 2022 [cited 2022 Dec 22]. Available from:https:\/\/www.boehringer\u2010ingelheim.com\/human\u2010health\/skin\u2010diseases\/gpp\/european\u2010commission\u2010approves\u2010spevigo\u2010spesolimab\u2010generalized"},{"key":"e_1_2_10_32_1","unstructured":"Boehringer\u2010Ingelheim.First\u2010ever treatment aimed at alleviating acute symptoms in pustular psoriasis [media release]. 2022 [cited 2022 Dec 22]. Available from:https:\/\/www.boehringer\u2010ingelheim.jp"},{"key":"e_1_2_10_33_1","unstructured":"Boehringer\u2010ingelheim.The spesolimab injection approved for marketing. 2022 [cited 2022 Jan 10]. Available from:https:\/\/www.ccfdie.org\/en\/gzdt\/webinfo\/2022\/12\/1668877790372263.htm"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00653-0"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18999"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12070"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18103"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00493-0"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.107"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1811317"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00658-9"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00654-z"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.19808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:09:36Z","timestamp":1732853376000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.19808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10.1111\/jdv.19808"],"URL":"https:\/\/doi.org\/10.1111\/jdv.19808","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,27]]},"assertion":[{"value":"2023-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}